Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 405.48B | 381.99B | 352.30B | 317.69B | 288.33B |
Gross Profit | 80.99B | 68.88B | 64.33B | 63.43B | 58.26B |
EBITDA | 64.33B | 54.48B | 45.08B | 45.18B | 41.80B |
Net Income | 31.96B | 25.16B | 19.94B | 23.95B | 20.19B |
Balance Sheet | |||||
Total Assets | 337.09B | 311.39B | 277.36B | 260.11B | 232.99B |
Cash, Cash Equivalents and Short-Term Investments | 71.33B | 65.24B | 61.36B | 75.27B | 62.74B |
Total Debt | 263.00M | 392.00M | 480.00M | 652.00M | 1.31B |
Total Liabilities | 84.05B | 84.72B | 70.64B | 65.89B | 57.90B |
Stockholders Equity | 253.04B | 226.67B | 206.72B | 194.22B | 175.08B |
Cash Flow | |||||
Free Cash Flow | 13.50B | 16.06B | -3.95B | 17.43B | 6.84B |
Operating Cash Flow | 52.69B | 48.47B | 23.77B | 38.86B | 27.88B |
Investing Cash Flow | -44.76B | -14.18B | -32.22B | -20.77B | -44.05B |
Financing Cash Flow | -5.84B | -5.42B | -5.46B | -5.57B | -4.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥245.97B | 24.10 | 9.46% | 0.50% | 18.37% | 43.55% | |
73 Outperform | ¥687.06B | 46.10 | 8.69% | 0.53% | 14.04% | 68.19% | |
72 Outperform | €1.30T | 34.31 | 17.11% | 0.85% | 17.70% | 26.84% | |
69 Neutral | ¥114.40B | 36.34 | 0.81% | 3.36% | 22.37% | ||
67 Neutral | ¥253.34B | 13.18 | 6.44% | 2.78% | 5.06% | -11.83% | |
66 Neutral | $791.11B | 24.08 | 13.46% | 0.82% | 3.58% | 23.45% | |
56 Neutral | ¥114.53B | 52.41 | 0.40% | 20.85% | -25.02% |